Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice

被引:49
|
作者
Ramos-Junior, Erivan S. [1 ]
Leite, Gisele A. [2 ]
Carmo-Silva, Cecilia C. [1 ]
Taira, Thaise M. [2 ]
Neves, Karla B. [3 ]
Colon, David F. [3 ]
da Silva, Lea A. B. [2 ]
Salvador, Sergio L. [4 ]
Tostes, Rita C. [3 ]
Cunha, Fernando Q. [3 ]
Fukada, Sandra Y. [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Pediat Dent, Sao Paulo, Brazil
[3] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pharmacol, Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Clin Analyses, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
ADIPOKINE; CHEMERIN; OSTEOCLASTS; METABOLISM; DYSLIPIDEMIA; OSTEOCLAST DIFFERENTIATION; RHEUMATOID-ARTHRITIS; INFLAMMATION; OBESITY; CELLS; RECEPTOR; DISEASE; CHEMR23; LIGAND; ADIPOGENESIS;
D O I
10.1002/jbmr.3072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemerin is an adipokine that regulates adipogenesis and metabolic functions of mature adipocytes mainly through the activation of chemokine-like receptor 1 (CMKLR1). Elevated levels of chemerin have been found in individuals with obesity, type 2 diabetes, and osteoporosis. This adipokine was identified as an inflammatory and metabolic syndrome marker. Considering that the association between metabolic syndrome and bone health remains unclear, the present study aimed to clarify the role of chemerin in the pathophysiology of bone loss induced by dyslipidemia, particularly modulating osteoclastogenesis. In vitro analyses showed a downregulation of CMKLR1 at the early stage of differentiation and a gradual increase at late stages. Strikingly, chemerin did not modify osteoclast differentiation markers or osteoclast formation; however, it increased the actin-ring formation and bone resorption activity in mature osteoclasts. The increased bone resorption activity induced by chemerin was effectively inhibited by CMKLR1 antagonist (CCX832). Chemerin boosting mature osteoclast activity involves ERK5 phosphorylation. Moreover, two models of dyslipidemia (high-fat diet [HFD]-treated C57/BL6 and db/db mice) exhibited significantly increased level of chemerin in the serum and gingival tissue. Morphometric analysis showed that HFD-treated and db/db mice exhibited increased alveolar bone loss compared to respective control mice, which was associated with an up-regulation of chemerin, CMKLR1 and cathepsin K mRNA expression in the gingival tissue. The treatment of db/db mice with CCX832 effectively inhibited bone loss. Antagonism of chemerin receptor also inhibited the expression of cathepsin K in the gingival tissue. Our results show that chemerin not only increases osteoclasts activity in vitro, but also that increased level of chemerin in dyslipidemic mice plays a critical role in bone homeostasis. (c) 2016 American Society for Bone and Mineral Research.
引用
收藏
页码:974 / 984
页数:11
相关论文
共 50 条
  • [41] Increased Bone Mass in Mice Lacking the Adipokine Apelin
    Wattanachanya, Lalita
    Lu, Wei-Dar
    Kundu, Ramendra K.
    Wang, Liping
    Abbott, Marcia J.
    O'Carroll, Dylan
    Quertermous, Thomas
    Nissenson, Robert A.
    ENDOCRINOLOGY, 2013, 154 (06) : 2069 - 2080
  • [42] Simvastatin Inhibits LPS-induced Alveolar Bone Loss during Metabolic Syndrome
    Jin, J.
    Machado, E. R.
    Yu, H.
    Zhang, X.
    Lu, Z.
    Li, Y.
    Lopes-Virella, M. F.
    Kirkwood, K. L.
    Huang, Y.
    JOURNAL OF DENTAL RESEARCH, 2014, 93 (03) : 294 - 299
  • [43] Long-term metabolic syndrome is associated with periodontal pockets and alveolar bone loss
    Tegelberg, Paula
    Tervonen, Tellervo
    Knuuttila, Matti
    Jokelainen, Jari
    Keinanen-Kiukaanniemi, Sirkka
    Auvinen, Juha
    Ylostalo, Pekka
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2019, 46 (08) : 799 - 808
  • [44] THE EFFECTS OF DIPHOSPHONATES ON LOSS OF ALVEOLAR BONE
    SCHMIDT, LJ
    ROWE, DJ
    JOURNAL OF DENTAL RESEARCH, 1984, 63 : 268 - 268
  • [45] ALVEOLAR BONE LOSS IN WILD BABOONS
    HILDEBOLT, CF
    PHILLIPSCONROY, JE
    JOLLY, CJ
    SCHAEFFER, J
    AMERICAN JOURNAL OF PRIMATOLOGY, 1993, 29 (01) : 61 - 72
  • [46] Radiographic assessment of alveolar bone loss
    Huerta, CJ
    Otis, LL
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A38 - A38
  • [47] BONE LOSS OF EDENTULOUS ALVEOLAR RIDGES
    ATWOOD, DA
    JOURNAL OF PERIODONTOLOGY, 1979, : 11 - 21
  • [48] Aging Quantification on Alveolar Bone Loss
    Sarajlic, Nermin
    Topic, Berislav
    Brkic, Hrvoje
    Alajbeg, Iva Z.
    COLLEGIUM ANTROPOLOGICUM, 2009, 33 (04) : 1165 - 1170
  • [49] SYSTEMIC FACTORS IN ALVEOLAR BONE LOSS
    BAYLINK, DJ
    WERGEDAL, JE
    YAMAMOTO, K
    MANZKE, E
    JOURNAL OF PROSTHETIC DENTISTRY, 1974, 31 (05): : 486 - 505
  • [50] Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice
    Baker, PJ
    Dixon, M
    Roopenian, DC
    INFECTION AND IMMUNITY, 2000, 68 (10) : 5864 - 5868